# Evaluation of the BD OneFlow Acute Leukemia Panel on the BD FACSLyric Flow Cytometer

> **NCT05035615** · — · COMPLETED · sponsor: **Becton, Dickinson and Company** · enrollment: 332 (actual)

## Conditions studied

- Acute Leukemia

## Interventions

- **DIAGNOSTIC_TEST:** IUO Acute Leukemia Panel

## Key facts

- **NCT ID:** NCT05035615
- **Lead sponsor:** Becton, Dickinson and Company
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-02
- **Primary completion:** 2024-06-29
- **Final completion:** 2024-07-18
- **Target enrollment:** 332 (ACTUAL)
- **Last updated:** 2024-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05035615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05035615, "Evaluation of the BD OneFlow Acute Leukemia Panel on the BD FACSLyric Flow Cytometer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05035615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*